A study published last month in Nature underscores the potential for a new personalized pancreatic cancer vaccine to keep the disease from coming back. The trial was tiny, just 16 patients, but it’s ...
A clinical trial from Memorial Sloan Kettering Cancer Center looked at the effects of a targeted mRNA vaccine on early-stage ...
Friends, family, and the Cathedral Prep community gathered at the Hagerty Family Events Center to honor the legendary Pat ...
News-Medical.Net on MSN4d
Targeted nanoparticles show promise in preventing pancreatic cancer spread to the liverPancreatic cancer remains one of the most challenging tumors to treat, partly because it is often discovered at advanced ...
The PAC-MANN test was able to differentiate — 98% of the time — between the blood of someone with pancreatic cancer and the ...
Pancreatic cancer that spreads to the liver is especially difficult to treat because the liver naturally suppresses immune ...
ZME Science on MSN4d
A Simple Blood Test Called PAC-MANN Could Detect Pancreatic Cancer Early and Save Thousands of LivesA new study from researchers at the Oregon Health and Science University (OHSU) proposes a test called PAC-MANN, which could ...
A personalized mRNA vaccine appeared to reduce the chances of pancreatic cancer returning after surgery, according to a study ...
Pancreatic cancer remains difficult to treat, and is responsible for around 8 percent of all cancer deaths.It also has one of ...
The five-year survival rate of people diagnosed with pancreatic cancer is currently 13 percent. Two breakthroughs are ...
A new assay rapidly detected pancreatic ductal adenocarcinoma and differentiated it from noncancer pancreatic diseases by ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback